Induced sputum eicosanoid concentrations in asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 6, 1999, Pages 1905-1909

  Pavord, Ian D ^a,b   Ward, Richard ^a,b   Woltmann, Gerrit ^a,b   Wardlaw, Andrew J ^a,b   Sheller, James R ^a,b   Dworski, Ryszard ^a,b  

^a GLENFIELD HOSPITAL   (United Kingdom)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOTRIENE; PROSTAGLANDIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; THROMBOXANE B2;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GEOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; ICOSANOID METABOLISM; MALE; PRIORITY JOURNAL; SPUTUM ANALYSIS;

EID: 0033456233     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.6.9903114     Document Type: Article

References (27)

1. Drazen, J. M. 1995. Cysteinyl leukotrienes. In W. W. Busse and S. T. Holgate, editors. Asthma and Rhinitis, 1st ed. Blackwell Scientific Publications, Oxford. 838-850.
2. Pang, L., A. Pitt, D. Petkova, and A. J. Knox. 1998. The cox-1/cox-2 balance in asthma. Clin. Exp. Allergy 28:1050-1058.
3. 4 in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J. Allergy Clin. Immunol. 84:19-26.
4. 2 and other bronchoconstricting prostaglandins in the airway of subjects with mild asthma. Am. Rev. Respir. Dis. 142:126-132.
5. 4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet i:584-587.
6. 4 concentrations increase after aspirin challenge in aspirin-sensitive patients. Am. Rev. Respir. Dis. 143:1025-1029.
7. Pavord, I. D., M. M. M. Pizzichini, E. Pizzichini, and F. E. Hargreave. 1997. The use of induced sputum to investigate airway inflammation. Thorax 52:498-501.
8. Pizzichini, E., M. M. M. Pizzichini, A. Efthimiadis, S. Evans, M. M. Morris, D. Squillace, G. J. Gleich, J. Dolovich, and F. E. Hargreave. 1996. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid phase measurements. Am. J. Respir. Crit. Care Med. 154:308-317.
9. The British Guidelines on Asthma Management. 1997. 1995 review and position statement. Thorax 52:S1-S20.
10. Juniper, E. F., D. W. Cockcroft, and F. E. Hargreave. 1994. Histamine and Methacholine Inhalation Tests: A Laboratory Tidal Breathing Protocol, 2nd ed. Astra Draco AB, Lund, Sweden.
11. ICSH. 1984. Reference method for staining blood and bone marrow films by azure B and cosin Y (Romanowsky stain). Br. J. Haematol. 57:707-710.
12. Sladek, K., R. Dworski, J. Soja, J. R. Sheller, E. Nizankowska, J. A. Oates, and A. Szczeklik. 1994. Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am. J. Respir. Crit. Care Med. 149:940-946.
13. Chinn, S. 1991. Repeatability and method comparison. Thorax 46:454-456.
14. Dworski, R., G. A. Fitzgerald, J. A. Oates, J. R. Sheller, R. Workman, and C. Prakash. 1994. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am. J. Respir. Crit. Care Med. 149:953-959.
15. Pizzichini, M. M. M., T. A. Popov, A. Efthimiadis, P. Hussack, S. Evans, E. Pizzichini, J. Dolovich, and F. E. Hargreave. 1996. Spontaneous and induced sputum to measure indices of airway inflammation. Am. J. Respir. Crit. Care Med. 154:866-869.
16. Turnbull, L. S., L. W. Turnbull, A. G. Leitch, J. W. Crofton, and A. B. Kay. 1977. Mediators of immediate-type hypersensitivity in sputum from patients with chronic bronchitis and asthma. Lancet ii:526-529.
17. O'Driscoll, B. R. C., O. Cromwell, and A. B. Kay. 1984. Sputum leukotrienes in obstructive airways disease. Clin. Exp. Allergy 55:397-404.
18. Wenzel, S. E., J. Y. Westcott, and G. L. Larsen. 1991. Bronchoalveolar lavage mediator levels 5 minutes after allergen challenge in atopic subjects with asthma: relationship to the development of the late response. J. Allergy Clin. Immunol. 87:540-548.
19. Dworski, R., and J. R. Sheller. 1998. Urinary mediators and asthma. Clin. Exp. Allergy 28:1309-1312.
20. 4 from the urine of patients with airway obstruction. Am. Rev. Respir. Dis. 146:104-108.
21. 4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Thorax 52:1030-1035.
22. 4 excretion in exercise-induced asthma. J. Appl. Physiol. 73:743-748.
23. Wenzel, S. E., J. Y. Westcott, H. R. Smith, and G. L. Larsen. 1989. Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups: an alteration in the ratio of bronchoconstrictive to bronchoprotective mediators. Am. Rev. Respir. Dis. 139:450-457.
24. 2. Lancet 344:436-438.
25. 2 on allergen-induced asthma. Am. Rev. Respir. Dis. 148:87-90.
26. 2 on allergen-induced airway responses and inflammation. Am. J. Respir. Crit. Care Med. 159:31-36.
27. Holtzman, M. J. 1991. Arachidonic acid metabolism. Implications of biological chemistry for lung function and disease. Am. Rev. Respir. Dis. 143:188-203.